Hemanext Latest News Updates

Hemanext to Present New Red Blood Cell Research Data at AABB 2020

Hemanext to Present New Red Blood Cell Research Data at AABB 2020 Four abstracts add to the growing body of evidence supporting hypoxic storage of RBCs LEXINGTON, Mass., September 29, 2020 Hemanext Inc., a privately held medical technology company dedicated to...

Celebrating David Herman (1946-2020)

News

Celebrating David Herman (1946 – 2020) With deep sadness, we record the untimely death in London on June 3rd of our fellow Board Director, investor and friend, David Herman. David served Hemanext as a member of the board for 10 years. He brought to this role a...

Help Shine the Light on Sickle Cell Disease

News, SCDAA

Join Us June 19th! Help Shine the Light on Sickle Cell Disease On June 19th, people around the globe will come together to recognize the United Nation’s World Sickle Cell Awareness Day through a wide variety of online activities. The celebration is called Shine the...

Thalassaemia International Federation and Hemanext® Inc. Announce New Strategic Alliance

TIF, News, Press Release

Thalassaemia International Federation and Hemanext® Inc. Announce New Strategic Alliance Organizations create partnership to support the needs of people living with hemoglobin disorders NICOSIA, Cyprus and LEXINGTON, Mass., June 10, 2020 The Thalassaemia International...

Sickle Cell Disease Association of America, Inc. and Hemanext® Inc. Form New Strategic Partnership

News, Press Release, SCDAA

Sickle Cell Disease Association of America, Inc. and Hemanext® Inc. Form New Strategic Partnership New alliance designed to enhance the lives of people living with sickle cell disease HANOVER, Md. and LEXINGTON, Mass., May 6, 2020 Sickle Cell Disease Association of...

Hemanext Announces CE Mark Submission for the HEMANEXT ONE Red Blood Cell Processing System

News, Press Release

Hemanext Announces CE Mark Submission for the HEMANEXT ONE Red Blood Cell Processing System Regulatory filing is a major step toward commercialization of transfusion-medicine innovation LEXINGTON, Mass., November 1, 2019 Hemanext Inc., a privately held medical...

« Older Entries

Next Entries »

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

YOU ARE ABOUT TO EXIT A US HEMANEXT CORPORATE WEBSITE FOR A GLOBAL HEMANEXT ONE PRODUCT WEBSITE